Skip to content

SUBclavian Central Venous Catheters Guidance and Examination by UltraSound

SUBclavian Central Venous Catheters Guidance and Examination by UltraSound : a Randomized Controlled Study Versus Landmark Method

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01888094
Acronym
SUBGEUS
Enrollment
300
Registered
2013-06-27
Start date
2013-06-30
Completion date
2015-12-31
Last updated
2016-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult Patients, Patient Covered by French Health Care System, Requiring Subclavian Vein Cannulation

Keywords

Central venous catheter, Complications, Ultrasound, Subclavian vein cannulation, Critical care, Echocardiography, Chest radiographyiography

Brief summary

Prospective, randomized controlled clinical unicentric study, in ICU, Cannulation of the subclavian venous and examination guided with ultrasound

Detailed description

One groupe : Ultrasound guided for cannulation and examination of absence ofcomplications One groupe : landmark method and examination with chest radiography

Interventions

OTHERUltrasound-guided cannulation and examination

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adults patients * requiring subclavian vein cannulation * patient covered by french health care system

Exclusion criteria

* patient refusal * requiring vein cannulation femoral or jugular * we see nothing with echocardiography * children and not adult patients

Design outcomes

Primary

MeasureTime frame
procedure time between the beginning of procedure ( TO) and when the catheter is controlled ( T4) between strategy catheter cannulation 'standard' and a strategy called ultrasound allat day 1

Secondary

MeasureTime frame
procedure time Tn-Tn (n 0-5) between the two strategies.at day 1
incidence of occurrence of complications: pneumothorax, hemothorax, bad positioning (outside of the superior vena cava or the right atrium) between the two strategiesat day 1
failure of technology between the two strategies.at day 1
occurrence of central venous catheter infection.at day 1

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026